Creative Planning’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Buy
11,884
+1,728
+17% +$113K ﹤0.01% 2450
2026
Q1
$80.3K Buy
10,156
+5,836
+135% +$94.4K ﹤0.01% 3938
2025
Q4
$74.4K Sell
4,320
-1,699
-28% -$32.9K ﹤0.01% 3753
2025
Q3
$155K Sell
6,019
-820
-12% -$31K ﹤0.01% 3573
2025
Q2
$393K Buy
6,839
+1,022
+18% +$82K ﹤0.01% 2670
2025
Q1
$630K Buy
5,817
+1,829
+46% +$159K ﹤0.01% 2086
2024
Q4
$189K Buy
3,988
+2,221
+126% +$134K ﹤0.01% 2986
2024
Q3
$174K Sell
1,767
-906
-34% -$117K ﹤0.01% 2888
2024
Q2
$437K Buy
2,673
+1,450
+119% +$207K ﹤0.01% 2048
2024
Q1
$187K Buy
+1,223
New +$203K ﹤0.01% 2586

Other funds holding AGL

Creative Planning's AGL Position: Q2 2026 in Review

Creative Planning increased its Agilon Health (AGL) stake by 17% in Q2 2026, buying an estimated $113K and bringing the position to 11,884 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2450.

Creative Planning first reported a position in AGL in Q1 2024 and has held it in 10 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Creative Planning held 11,884 shares of Agilon Health worth $1.27M as of Q2 2026.
  • Creative Planning bought 1,728 Agilon Health shares in Q2 2026, an estimated $113K.
  • Agilon Health made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2450 holding.
  • Creative Planning first reported a position in Agilon Health in Q1 2024 and has held it in 10 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.